ES2109190B1 - Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht - Google Patents

Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht

Info

Publication number
ES2109190B1
ES2109190B1 ES9600700A ES9600700A ES2109190B1 ES 2109190 B1 ES2109190 B1 ES 2109190B1 ES 9600700 A ES9600700 A ES 9600700A ES 9600700 A ES9600700 A ES 9600700A ES 2109190 B1 ES2109190 B1 ES 2109190B1
Authority
ES
Spain
Prior art keywords
new
serotoninergic receptors
affinated
bencimidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9600700A
Other languages
English (en)
Other versions
ES2109190A1 (es
Inventor
Rodriguez Maria Luz Lopez
Ortega Maria Jose Morcillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Priority to ES9600700A priority Critical patent/ES2109190B1/es
Priority to AU21607/97A priority patent/AU2160797A/en
Priority to PCT/ES1997/000068 priority patent/WO1997035860A1/es
Publication of ES2109190A1 publication Critical patent/ES2109190A1/es
Application granted granted Critical
Publication of ES2109190B1 publication Critical patent/ES2109190B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE BENCIMIDAZOL CON AFINIDAD POR LOS RECEPTORES SEROTONINERGICOS 5-HT3/5-HT4. LA PRESENTE INVENCION TRATA DE NUEVOS COMPUESTOS DE FORMULA GENERAL I, DONDE X ES OXIGENO O NITROGENO; R ES HIDROGENO O CLORO; R'' ES HIDROGENO, NITRO O AMINO; E Y ES AZABICICLO [X.Y.Z] ALQUILO, N-ALQUILPIPERIDILO O DIALQUILAMINOALQUILO. SE DESCRIBEN LOS METODOS DE PREPARACION DE DICHOS COMPUESTOS, LOS CUALES HAN MOSTRADO UNA ELEVADA AFINIDAD POR LOS RECEPTORES SEROTONINERGICOS 5-HT3 Y/O 5-HT4, LO QUE INDICA SU INTERES DESDE EL PUNTO DE VISTA TERAPEUTICO EN EL TRATAMIENTO DE LA EMESIS PROVOCADA POR LA QUIMIOTERAPIA, Y EN EL TRATAMIENTO DE ALTERACIONES GASTROINTESTINALES Y NEURONALES, TALES COMO LA ANSIEDAD, LA PSICOSIS, LA DROGODEPENDENCIA Y LOS TRASTORNOS COGNITIVOS.
ES9600700A 1996-03-22 1996-03-22 Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht Expired - Fee Related ES2109190B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9600700A ES2109190B1 (es) 1996-03-22 1996-03-22 Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht
AU21607/97A AU2160797A (en) 1996-03-22 1997-03-18 Novel benzimidazol derivatives having an affinity for the serotoninergic 5-ht3/5 ht4 receptors
PCT/ES1997/000068 WO1997035860A1 (es) 1996-03-22 1997-03-18 Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht3/5-ht¿4?

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9600700A ES2109190B1 (es) 1996-03-22 1996-03-22 Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht

Publications (2)

Publication Number Publication Date
ES2109190A1 ES2109190A1 (es) 1998-01-01
ES2109190B1 true ES2109190B1 (es) 1998-07-01

Family

ID=8294288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9600700A Expired - Fee Related ES2109190B1 (es) 1996-03-22 1996-03-22 Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht

Country Status (3)

Country Link
AU (1) AU2160797A (es)
ES (1) ES2109190B1 (es)
WO (1) WO1997035860A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2154605B1 (es) * 1999-09-14 2001-11-16 Univ Madrid Complutense Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
HUP0402289A2 (hu) 2001-10-02 2005-02-28 Pharmacia & Upjohn Company Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US6849620B2 (en) 2001-10-26 2005-02-01 Pfizer Inc N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
US6951868B2 (en) 2001-11-09 2005-10-04 Pfizer Inc. Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
AU2003217275A1 (en) 2002-02-19 2003-09-09 Pharmacia And Upjohn Company Azabicyclic compounds for the treatment of disease
JP2005523288A (ja) 2002-02-19 2005-08-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
ES2199086B1 (es) 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
BRPI0414046A (pt) * 2003-08-29 2006-10-24 Dynogen Pharmaceuticals Inc método de tratamento de um distúrbio de motilidade gastrintestinal, de tratamento de "gerd", de "gerd" noturno, composição farmacêutica, kit que compreende um composto e método para aumentar a motilidade esofágica em um paciente
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
WO2006052889A2 (en) 2004-11-05 2006-05-18 Theravance, Inc. Quinolinone-carboxamide compounds
US7399862B2 (en) 2004-11-05 2008-07-15 Theravance, Inc. 5-HT4 receptor agonist compounds
CA2588037A1 (en) 2004-12-22 2006-06-29 Theravance, Inc. Indazole-carboxamide compounds
NZ560969A (en) 2005-02-17 2010-08-27 Albany Molecular Res Inc Benzoxazole carboxamides for treating chemotherapy-induced vomiting and irritable bowel syndrome
CN101163701A (zh) 2005-03-02 2008-04-16 施万制药 作为5-ht4受体激动剂的喹啉酮化合物
MY147756A (en) 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
US7256294B2 (en) 2005-05-25 2007-08-14 Theravance, Inc. Crystalline form of a benzimidazole-carboxamide medicinal compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5300512A (en) * 1992-06-24 1994-04-05 G. D. Searle & Co. Benzimidazole compounds
WO1995003298A1 (en) * 1993-07-19 1995-02-02 Fujisawa Pharmaceutical Co., Ltd. BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST

Also Published As

Publication number Publication date
ES2109190A1 (es) 1998-01-01
WO1997035860A1 (es) 1997-10-02
AU2160797A (en) 1997-10-17

Similar Documents

Publication Publication Date Title
ES2109190B1 (es) Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht
PE11898A1 (es) Nuevos inhibidores de la farnesiltransferasa, su preparacion y los compuestos farmaceuticos que los contienen
SE9904508D0 (sv) New compounds
SV1999000141A (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos ref. pc10411abcz/bb
HN1999000080A (es) Derivados de isotiazol utiles como agentes anticancerosos.
BR0315317A (pt) 4-piperazinil benzenossulfonil indóis com afinidade para o receptor de 5-ht6
BR0208179A (pt) Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto
UY26086A1 (es) Procedimientos e intermedios para preparar compuestos anticancerosos
DE69513219D1 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Anwendung
BR0214024A (pt) Derivados de 1,2,4-tiadiazol como moduladores de receptor de melanocortina
MA26962A1 (fr) Derives de benzodiazepine tels que gaba en tant que modulateurs de reception.
ATE417838T1 (de) Arylsulfonyl-derivate mit 5-ht 6-rezeptor- affinität
AR004480A1 (es) Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
ES2154605A1 (es) Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3
ATE313539T1 (de) Chinolin-4-carboxamidderivate als nk-3 und nk-2 rezeptor antagonisten
IL134894A (en) 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them
NL980015I1 (nl) Nieuwe 2-c(2,6-dichloorfenyl)amine!fenylacetoxyacetylderivaten, werkwijze voor de bereiding ervan enhun therapeutisch gebruik.
GB0507601D0 (en) Compounds
DE60202942D1 (de) Thiazolopyrimidine und deren verwendung als modulatoren der chemokinrezeptoraktivität
MX9200471A (es) N-(ariloxialquil)heteroaril-8-azabiciclo[3.2.1]octanos, compuestos intermedios y un procedimiento para su preparacion, asi como su uso en calidad de medicamentos
GT200500319A (es) Algunos metabolitos derivados de [1,4]diazepino[6,7,1-ij]quinolina y metodos para la preparacion y usos de los mismos.
ES2098186A1 (es) Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer.
ES2155898T3 (es) Derivados de azepina tetraciclica sustituidos, que presentan una afinidad por los receptores 5-ht2.
DK247784A (da) Spiro(indolo(1,7-ab)(1,5)benzodiazepin-2,4&#39;-piperidiner), fremgangsmaade til fremstilling deraf samt mellemprodukter til brug herved, og deres anvendelse som laegemidler
BR1100564A (pt) Formas cristalinas de mono-hidrato do cloridrato de endo-2,3-dihidro-n-(8-metil-8-azabiciclo[3.2.1]oct-3-il)-2 - -oxo-1h-benzimidazol-1-carboxamida e de mono-hidrato do cloridrato de endo-3-etil-2,3-di-hidro-n-(8-metil-8-azabiciclo[3.2.1]oc t-3-il)-2-oxo-1h-benzimidazol-1-carboxamida como antagonistas do 5-ht

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980101

Kind code of ref document: A1

Effective date: 19980101

FD2A Announcement of lapse in spain

Effective date: 20160629